Eray Alper

Bursa, 16059, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Software-Assisted Subtraction with Ultrasound-Correlated Interpretation Reduces Interpretive Ambiguity in Parathyroid Scintigraphy: A Preliminary Prospective Reporting Study.

Software-Assisted Subtraction with Ultrasound-Correlated Interpretation Reduces Interpretive Ambiguity in Parathyroid Scintigraphy: A Preliminary Prospective Reporting Study.

Journal: Diagnostics (Basel, Switzerland)

Published: June 21, 2026

FDG PET/CT as the Decisive Modality in Distinguishing Clear Cell Sarcoma from Melanoma When Immunohistochemistry Overlaps: A Case Report.

FDG PET/CT as the Decisive Modality in Distinguishing Clear Cell Sarcoma from Melanoma When Immunohistochemistry Overlaps: A Case Report.

Journal: World journal of nuclear medicine

Published: May 04, 2026

When PSMA is not enough: the diagnostic blind spots of PSMA PET/CT and the added value of [¹⁸F]FDG in high-risk prostate cancer: dual-tracer cohort study.

When PSMA is not enough: the diagnostic blind spots of PSMA PET/CT and the added value of [¹⁸F]FDG in high-risk prostate cancer: dual-tracer cohort study.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: May 03, 2026

Concerns Regarding Brain [18F]FDG SUVmean as a Prognostic Biomarker in Advanced Non-Small Cell Lung Cancer.

Concerns Regarding Brain [18F]FDG SUVmean as a Prognostic Biomarker in Advanced Non-Small Cell Lung Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: April 17, 2026

Divergent PET Tracer Avidity in Synchronous Sarcomatoid Carcinoma With Osteosarcomatous Differentiation and Adenocarcinoma of the Prostate: Insights From Dual-Tracer 68 Ga-PSMA and 18 F-FDG PET/CT Imaging.

Divergent PET Tracer Avidity in Synchronous Sarcomatoid Carcinoma With Osteosarcomatous Differentiation and Adenocarcinoma of the Prostate: Insights From Dual-Tracer 68 Ga-PSMA and 18 F-FDG PET/CT Imaging.

Journal: Clinical nuclear medicine

Published: March 11, 2026

[⁶⁸Ga]Ga-PSMA PET/CT Suggested Tumor Recurrence in a Treated Oligodendroglioma.

[⁶⁸Ga]Ga-PSMA PET/CT Suggested Tumor Recurrence in a Treated Oligodendroglioma.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: January 15, 2026

The evolving role of [¹⁸F]FDG PET/CT in reducing or replacing biopsy in selected malignancies: A narrative literature review.

The evolving role of [¹⁸F]FDG PET/CT in reducing or replacing biopsy in selected malignancies: A narrative literature review.

Journal: Journal of medical imaging and radiation sciences

Published: July 11, 2025

Prognostic value of pretreatment tumor-to-blood standardized uptake ratio (SUR) in rectal cancer.

Prognostic value of pretreatment tumor-to-blood standardized uptake ratio (SUR) in rectal cancer.

Journal: Annals of nuclear medicine

Published: January 17, 2020

The impact of PET/CT imaging performed in the early postoperative period on the management of breast cancer patients.

The impact of PET/CT imaging performed in the early postoperative period on the management of breast cancer patients.

Journal: Nuclear medicine communications

Published: April 04, 2013

99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.

99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.

Journal: Nuclear medicine communications

Published: April 30, 2003

Showing 1-10 of 10

Last Updated: 09/26/2026